載入...
High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin
The anti-CD20 mAb Rituximab has revolutionized lymphoma therapy, in spite of a number of unresponsive or relapsing patients. Immunotoxins, consisting of toxins coupled to antibodies, are being investigated for their potential ability to augment Rituximab efficacy. Here, we compare the anti-tumor eff...
Na minha lista:
| 發表在: | Toxins (Basel) |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4926157/ https://ncbi.nlm.nih.gov/pubmed/27338475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins8060192 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|